254 related articles for article (PubMed ID: 21310825)
1. The androgen receptor induces integrin α6β1 to promote prostate tumor cell survival via NF-κB and Bcl-xL Independently of PI3K signaling.
Lamb LE; Zarif JC; Miranti CK
Cancer Res; 2011 Apr; 71(7):2739-49. PubMed ID: 21310825
[TBL] [Abstract][Full Text] [Related]
2. Androgen receptor-induced integrin α6β1 and Bnip3 promote survival and resistance to PI3K inhibitors in castration-resistant prostate cancer.
Nollet EA; Cardo-Vila M; Ganguly SS; Tran JD; Schulz VV; Cress A; Corey E; Miranti CK
Oncogene; 2020 Jul; 39(31):5390-5404. PubMed ID: 32565538
[TBL] [Abstract][Full Text] [Related]
3. Androgen receptor non-nuclear regulation of prostate cancer cell invasion mediated by Src and matriptase.
Zarif JC; Lamb LE; Schulz VV; Nollet EA; Miranti CK
Oncotarget; 2015 Mar; 6(9):6862-76. PubMed ID: 25730905
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological inhibition of androgen receptor expression induces cell death in prostate cancer cells.
Song IS; Jeong YJ; Kim J; Seo KH; Baek NI; Kim Y; Kim CS; Jang SW
Cell Mol Life Sci; 2020 Nov; 77(22):4663-4673. PubMed ID: 31894360
[TBL] [Abstract][Full Text] [Related]
5. The nuclear factor-kappaB pathway controls the progression of prostate cancer to androgen-independent growth.
Jin RJ; Lho Y; Connelly L; Wang Y; Yu X; Saint Jean L; Case TC; Ellwood-Yen K; Sawyers CL; Bhowmick NA; Blackwell TS; Yull FE; Matusik RJ
Cancer Res; 2008 Aug; 68(16):6762-9. PubMed ID: 18701501
[TBL] [Abstract][Full Text] [Related]
6. Interplay of nuclear factor-kappaB and B-myb in the negative regulation of androgen receptor expression by tumor necrosis factor alpha.
Ko S; Shi L; Kim S; Song CS; Chatterjee B
Mol Endocrinol; 2008 Feb; 22(2):273-86. PubMed ID: 17975021
[TBL] [Abstract][Full Text] [Related]
7. Androgen receptor-dependent regulation of Bcl-xL expression: Implication in prostate cancer progression.
Sun A; Tang J; Hong Y; Song J; Terranova PF; Thrasher JB; Svojanovsky S; Wang HG; Li B
Prostate; 2008 Mar; 68(4):453-61. PubMed ID: 18196538
[TBL] [Abstract][Full Text] [Related]
8. Role of PI3K-AKT-mTOR Pathway as a Pro-Survival Signaling and Resistance-Mediating Mechanism to Therapy of Prostate Cancer.
Pungsrinont T; Kallenbach J; Baniahmad A
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681745
[TBL] [Abstract][Full Text] [Related]
9. PI3K-AKT-mTOR pathway is dominant over androgen receptor signaling in prostate cancer cells.
Kaarbø M; Mikkelsen OL; Malerød L; Qu S; Lobert VH; Akgul G; Halvorsen T; Maelandsmo GM; Saatcioglu F
Cell Oncol; 2010; 32(1-2):11-27. PubMed ID: 20203370
[TBL] [Abstract][Full Text] [Related]
10. Parathyroid hormone-related protein regulates cell survival pathways via integrin alpha6beta4-mediated activation of phosphatidylinositol 3-kinase/Akt signaling.
Bhatia V; Mula RV; Weigel NL; Falzon M
Mol Cancer Res; 2009 Jul; 7(7):1119-31. PubMed ID: 19584267
[TBL] [Abstract][Full Text] [Related]
11. The CXCL12/CXCR4 axis promotes ligand-independent activation of the androgen receptor.
Kasina S; Macoska JA
Mol Cell Endocrinol; 2012 Apr; 351(2):249-63. PubMed ID: 22245379
[TBL] [Abstract][Full Text] [Related]
12. Induction of androgen receptor expression by phosphatidylinositol 3-kinase/Akt downstream substrate, FOXO3a, and their roles in apoptosis of LNCaP prostate cancer cells.
Yang L; Xie S; Jamaluddin MS; Altuwaijri S; Ni J; Kim E; Chen YT; Hu YC; Wang L; Chuang KH; Wu CT; Chang C
J Biol Chem; 2005 Sep; 280(39):33558-65. PubMed ID: 16061480
[TBL] [Abstract][Full Text] [Related]
13. Phosphoinositide 3-OH kinase p85alpha and p110beta are essential for androgen receptor transactivation and tumor progression in prostate cancers.
Zhu Q; Youn H; Tang J; Tawfik O; Dennis K; Terranova PF; Du J; Raynal P; Thrasher JB; Li B
Oncogene; 2008 Jul; 27(33):4569-79. PubMed ID: 18372911
[TBL] [Abstract][Full Text] [Related]
14. Laminin-1 and alpha6beta1 integrin regulate acinar morphogenesis of normal and malignant human prostate epithelial cells.
Bello-DeOcampo D; Kleinman HK; Deocampo ND; Webber MM
Prostate; 2001 Feb; 46(2):142-53. PubMed ID: 11170142
[TBL] [Abstract][Full Text] [Related]
15. RELA is sufficient to mediate interleukin-1 repression of androgen receptor expression and activity in an LNCaP disease progression model.
Thomas-Jardin SE; Dahl H; Kanchwala MS; Ha F; Jacob J; Soundharrajan R; Bautista M; Nawas AF; Robichaux D; Mistry R; Anunobi V; Xing C; Delk NA
Prostate; 2020 Feb; 80(2):133-145. PubMed ID: 31730277
[TBL] [Abstract][Full Text] [Related]
16. Requirement for NF-(kappa)B in interleukin-4-induced androgen receptor activation in prostate cancer cells.
Lee SO; Lou W; Nadiminty N; Lin X; Gao AC
Prostate; 2005 Jul; 64(2):160-7. PubMed ID: 15678501
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of androgen receptor transactivation function by adenovirus type 12 E1A undermines prostate cancer cell survival.
Li D; Tian G; Wang J; Zhao LY; Co O; Underill ZC; Mymryk JS; Claessens F; Dehm SM; Daaka Y; Liao D
Prostate; 2018 Nov; 78(15):1140-1156. PubMed ID: 30009471
[TBL] [Abstract][Full Text] [Related]
18. Androgen receptor dampens tissue factor expression via nuclear factor-κB and early growth response protein 1.
Hoesel B; Mussbacher M; Dikorman B; Salzmann M; Assinger A; Hell L; Thaler J; Basílio J; Moser B; Resch U; Paar H; Mackman N; Schmid JA
J Thromb Haemost; 2018 Apr; 16(4):749-758. PubMed ID: 29427323
[TBL] [Abstract][Full Text] [Related]
19. Synthetic Lethality in PTEN-Mutant Prostate Cancer Is Induced by Combinatorial PI3K/Akt and BCL-XL Inhibition.
Ren W; Joshi R; Mathew P
Mol Cancer Res; 2016 Dec; 14(12):1176-1181. PubMed ID: 27590631
[TBL] [Abstract][Full Text] [Related]
20. Small-interfering RNA-induced androgen receptor silencing leads to apoptotic cell death in prostate cancer.
Liao X; Tang S; Thrasher JB; Griebling TL; Li B
Mol Cancer Ther; 2005 Apr; 4(4):505-15. PubMed ID: 15827323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
